Aquestive Therapeutics Inc Working Capital to Net Assets Ratio
Aquestive Therapeutics Inc working capital to net assets ratio. Aquestive Therapeutics Inc (AQST) has a Working Capital to Net Assets ratio of -289.0% as of March 2026. Working capital of $98.43 Million (current assets of $130.18 Million minus current liabilities of $31.75 Million) is measured against net assets of $-34.05 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Aquestive Therapeutics Inc (2005–2025)
Working capital to net assets ratio of Aquestive Therapeutics Inc from 2005 to 2025. This chart shows how Aquestive Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2005 to 2025. As of March 2026, the ratio stands at -289.0%, reflecting working capital of $98.43 Million against net assets of $-34.05 Million USD. Explore investment intensity of Aquestive Therapeutics Inc to see how much of total assets are deployed in long-term investments.
Aquestive Therapeutics Inc Working Capital to Net Assets Ratio by Year (2005–2025)
Aquestive Therapeutics Inc working capital to net assets ratio by year from 2005 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Aquestive Therapeutics Inc from 2005 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see AQST total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -302.0% | $101.66 Million | $-33.66 Million | $149.27 Million | $47.61 Million | ▼ -186.7 pp |
| 2024 | -115.3% | $69.36 Million | $-60.16 Million | $88.22 Million | $18.86 Million | ▼ -94.0 pp |
| 2023 | -21.3% | $22.66 Million | $-106.49 Million | $40.97 Million | $18.31 Million | ▼ -21.0 pp |
| 2022 | -0.3% | $360.00K | $-118.55 Million | $39.89 Million | $39.53 Million | ▲ +30.5 pp |
| 2021 | -30.8% | $25.30 Million | $-82.13 Million | $47.26 Million | $21.96 Million | ▲ +17.7 pp |
| 2020 | -48.5% | $23.52 Million | $-48.50 Million | $44.62 Million | $21.10 Million | ▲ +764.3 pp |
| 2019 | -812.8% | $49.76 Million | $-6.12 Million | $68.31 Million | $18.55 Million | ▼ -1222.0 pp |
| 2018 | 409.2% | $41.25 Million | $10.08 Million | $74.20 Million | $32.95 Million | ▲ +457.6 pp |
| 2017 | -48.4% | $12.81 Million | $-26.50 Million | $28.16 Million | $15.35 Million | ▲ +22.9 pp |
| 2016 | -71.3% | $12.53 Million | $-17.58 Million | $23.33 Million | $10.81 Million | ▼ -130.0 pp |
| 2006 | 58.7% | $14.83 Million | $25.26 Million | $16.66 Million | $1.83 Million | ▲ +46.3 pp |
| 2005 | 12.4% | $580.00K | $4.67 Million | $2.30 Million | $1.72 Million | — |